Caricamento...
Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches
The α-emitting radionuclide actinium-225 possesses nuclear properties that are highly promising for use in targeted α therapy (TAT), a therapeutic strategy that employs α particle emissions to destroy tumors. A key factor, however, that may hinder the clinical use of actinium-225 is the poor underst...
Salvato in:
| Pubblicato in: | Cancer Biother Radiopharm |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mary Ann Liebert, Inc., publishers
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207149/ https://ncbi.nlm.nih.gov/pubmed/29889562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2018.2494 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|